Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07570303
Promoting Walking Among Older Adults Through Nostalgia-Based Messages and Step-MonitoringCatholic University, ItalyNot Yet RecruitingNot Applicable
NCT07570303Not Yet Recruiting
Not Applicable
Promoting Walking Among Older Adults Through Nostalgia-Based Messages and Step-M...Catholic University, Ital...
NCT07571304
Dual-Task Training in Pediatric Multiple SclerosisIstanbul University - CerrahpasaRecruitingNot Applicable
NCT07571304Recruiting
Not Applicable
Dual-Task Training in Pediatric Multiple SclerosisIstanbul University - Cer...
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07569419
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisUniversity of NottinghamRecruitingEarly Phase 1
NCT07569419Recruiting
Early Phase 1
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosi...University of Nottingham
NCT07569315
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-respondersBedaya HospitalNot Yet RecruitingPhase 2
NCT07569315Not Yet Recruiting
Phase 2
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger O...Bedaya Hospital
NCT07569341
Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal MetastasesLinkoeping UniversityCompleted
NCT07569341Completed
—
Validation of the Classification for Resectability and Ablatability Criteria for...Linkoeping University
NCT07570498
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07570498Completed
Not Applicable
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of...
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
NCT07569055
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Guangxi Medical UniversityRecruiting
NCT07569055Recruiting
—
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoie...First Affiliated Hospital...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571330
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de Nuevo LeonRecruitingNot Applicable
NCT07571330Recruiting
Not Applicable
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de N...
NCT07569029
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesDepartment of Health and Human Services (HHS)Not Yet RecruitingPhase 1
NCT07569029Not Yet Recruiting
Phase 1
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA...Department of Health and...
NCT07571252
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto RicoNot Yet RecruitingPhase 4
NCT07571252Not Yet Recruiting
Phase 4
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto Rico
NCT07571109
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571109Not Yet Recruiting
Phase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07571772
The Effect of Hot Compress in Patients With Knee OsteoarthritisErcan BakırCompletedNot Applicable
NCT07571772Completed
Not Applicable
The Effect of Hot Compress in Patients With Knee OsteoarthritisErcan Bakır
NCT07568834
Impact of Pelvic Pain PodcastVanderbilt University Medical CenterRecruitingNot Applicable
Result Breakdown
Not yet recruiting9 (45%)
Recruiting7 (35%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)
Early Phase 11 (5%)
Phase 41 (5%)
Phase 31 (5%)